451 related articles for article (PubMed ID: 34475402)
1. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63.
Liu Y; Zhang P; Wu Q; Fang H; Wang Y; Xiao Y; Cong M; Wang T; He Y; Ma C; Tian P; Liang Y; Qin LX; Yang Q; Yang Q; Liao L; Hu G
Nat Commun; 2021 Sep; 12(1):5232. PubMed ID: 34475402
[TBL] [Abstract][Full Text] [Related]
2. lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.
Zhang Q; Li T; Wang Z; Kuang X; Shao N; Lin Y
J Cell Mol Med; 2020 Jul; 24(14):8236-8247. PubMed ID: 32548873
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression.
Zuo F; Zhang Y; Li J; Yang S; Chen X
Bioengineered; 2021 Dec; 12(2):12345-12356. PubMed ID: 34738863
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
5. The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis.
Li D; Xu M; Wang Z; Huang P; Huang C; Chen Z; Tang G; Zhu X; Cai M; Qin S
Cell Death Dis; 2022 Jan; 13(1):84. PubMed ID: 35082283
[TBL] [Abstract][Full Text] [Related]
6. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression.
Zhang C; Wu S; Song R; Liu C
Aging (Albany NY); 2020 Aug; 13(5):7660-7675. PubMed ID: 32784268
[TBL] [Abstract][Full Text] [Related]
8. NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641.
Zhong Y; Zeng W
J Healthc Eng; 2022; 2022():6778199. PubMed ID: 35083026
[TBL] [Abstract][Full Text] [Related]
9. NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis.
Hu J; Peng F; Qiu X; Yang J; Li J; Shen C; Yuan C
Curr Med Chem; 2023; 30(37):4266-4276. PubMed ID: 36644870
[TBL] [Abstract][Full Text] [Related]
10. ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells.
Kim EJ; Kim JS; Lee S; Cheon I; Kim SR; Ko YH; Kang K; Tan X; Kurie JM; Ahn YH
Cancer Lett; 2022 May; 533():215601. PubMed ID: 35176421
[TBL] [Abstract][Full Text] [Related]
11. NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.
Rodriguez-Tirado C; Kale N; Carlini MJ; Shrivastava N; Rodrigues AA; Khalil BD; Bravo-Cordero JJ; Hong Y; Alexander M; Ji J; Behbod F; Sosa MS
Cancer Res; 2022 Jun; 82(12):2313-2326. PubMed ID: 35471456
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells.
Wang J; Dong S; Zhang J; Jing D; Wang W; Dong L; Zhao Y
Cancer Biother Radiopharm; 2020 Dec; 35(10):760-764. PubMed ID: 32407174
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L; Zhao S; Mingxin YU
Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y; Chen S; Cai K; Zheng D; Zhu C; Li L; Wang F; He Z; Yu C; Sun C
Cell Death Dis; 2022 Mar; 13(3):232. PubMed ID: 35283481
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NR2F1-AS1 Inhibits the Malignant Properties of Cervical Cancer Cells via Targeting miR-642a-3p/NR2F1 Axis.
Zhang L; Zhang Y; Zhou J; Wang Y; Wang H; Huang M; Yu Q; Qi S
Rev Invest Clin; 2022; 74(4):181-192. PubMed ID: 36087939
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
Sanchez Calle A; Yamamoto T; Kawamura Y; Hironaka-Mitsuhashi A; Ono M; Tsuda H; Shimomura A; Tamura K; Takeshita F; Ochiya T; Yamamoto Y
Mol Oncol; 2020 Sep; 14(9):2271-2287. PubMed ID: 32392629
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ARAP1-AS1 promotes tumorigenesis and metastasis through facilitating proto-oncogene c-Myc translation via dissociating PSF/PTB dimer in cervical cancer.
Zhang Y; Wu D; Wang D
Cancer Med; 2020 Mar; 9(5):1855-1866. PubMed ID: 31953923
[TBL] [Abstract][Full Text] [Related]
18. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
[TBL] [Abstract][Full Text] [Related]
19. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
20. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.
Khalil BD; Sanchez R; Rahman T; Rodriguez-Tirado C; Moritsch S; Martinez AR; Miles B; Farias E; Mezei M; Nobre AR; Singh D; Kale N; Sproll KC; Sosa MS; Aguirre-Ghiso JA
J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34812843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
